c-Jun N-terminal kinase (JNK) regulation of iNOS expression in glial cells: Predominant role of JNK1 isoform

Antioxidants and Redox Signaling

Volumn 8, Issue 5-6, 2006, Pages 903-909

  Pawate, Siddharama ^a   Shen, Qin ^a,b   Bhat, Narayan R ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NANTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOENZYME; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 1; NUCLEAR FACTOR; RNA; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE 1; STRESS ACTIVATED PROTEIN KINASE INHIBITOR;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL ACTIVATION; CONTROLLED STUDY; DOWNSTREAM PROCESSING; ENZYME INDUCTION; ENZYME REGULATION; GENE; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC TRANSCRIPTION; GLIA CELL; INFLAMMATION; MOUSE; NEWBORN; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; STRESS; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ANIMALS; ANTHRACENES; ASTROCYTES; CELLS, CULTURED; ENZYME ACTIVATION; INTERFERON TYPE II; INTERFERON-GAMMA; ISOENZYMES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPOLYSACCHARIDES; MITOGEN-ACTIVATED PROTEIN KINASE 8; NITRIC OXIDE SYNTHASE TYPE II; RATS; RNA, SMALL INTERFERING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33745852641     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2006.8.903     Document Type: Article

References (31)

1. Barr RK and Bogoyevitch MA. The c-Jun N-terminal protein kinase family of mitogen-activated protein kinases (JNK MAPKs). Int J Biochem Cell Biol 33: 1047-1063, 2001.
2. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, Bhagwat SS, Manning AM, and Anderson DW. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 98: 13681-13686, 2001.
3. Bhat NR, Zhang P, Lee JC, and Hogan EL. Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures. J Neurosci 18: 1633-1641, 1998.
4. Bhat NR, Feinstein DL, Shen Q, and Bhat AN. p38 MAPK-mediated transcriptional activation of inducible nitric-oxide synthase in glial cells. Roles of nuclear factors, nuclear factor kappa B, cAMP response element-binding protein, CCAAT/enhancer-binding protein-beta, and activating transcription factor-2. J Biol Chem 277: 29584-29592, 2002.
5. Bhat NR, Shen Q, and Fan F. TAK1-mediated induction of nitric oxide synthase gene expression in glial cells. J Neurochem 87: 238-247, 2003.
6. Boje KM. Nitric oxide neurotoxicity in neurodegenerative diseases. Front Biosci 9: 763-776, 2004.
7. Butterfield L, Storey B, Maas L, and Heasley LE. c-Jun NH2-terminal kinase regulation of the apoptotic response of small cell lung cancer cells to ultraviolet radiation. J Biol Chem 111: 10110-10116, 1997.
8. Brecht S, Kirchhof R, Chromik A, Willesen M, Nicolaus T, Raivich G, Wessig J, Waetzig V, Goetz M, Claussen M, Pearse D, Kuan CY, Vaudano E, Behrens A, Wagner E, Flavell RA, Davis RJ, and Herdegen T. Specific pathophysiological functions of JNK isoforms in the brain. Eur J Neurosci 21: 363-377, 2005.
9. Conze D, Krahl T, Kennedy N, Weiss L, Lumsden J, Hess P, Flavell RA, Le Gros G, Davis RJ, and Rincon M. c-Jun NH(2)-terminal kinase (JNK)1 and JNK2 have distinct roles in CD8(+) T cell activation. J Exp Med 195: 811-823, 2002.
10. del Zoppo G, Ginis I, Hallenbeck JM, Iadecola C, Wang X, and Feuerstein GZ. Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia. Brain Pathol 10: 95-112, 2000.
11. Duncan AJ and Heales SJ. Nitric oxide and neurological disorders. Mol Aspects Med 26: 67-96, 2005.
12. Fanger GR, Gerwins P, Widman C, Jarpe MB, and Johnson GL. MEKKs, GCKs, MLKs, PAKs, TAKs, and tpls: upstream regulators of the c-Jun amino-terminal kinases? Curr Opin Genet Dev 7: 67-74, 1997.
13. Fogarty MP, Downer EJ, and Campbell V. A role for c-Jun N-terminal kinase 1 (JNK1), but not JNK2, in the beta-amyloid-mediated stabilization of protein p53 and induction of the apoptotic cascade in cultured cortical neurons. Biochem J 371: 789-798, 2003.
14. Gupta S, Barrett T, Whitmarsh AJ, Cavanagh J, Sluss HK, Derijard B, and Davis RJ. Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J 15: 2760-2770, 1996.
15. Hreniuk D, Garay M, Gaarde W, Monia BP, McKay RA, and Cioffi CL. Inhibition of c-Jun N-terminal kinase 1, but not c-Jun N-terminal kinase 2, suppresses apoptosis induced by ischemia/reoxygenation in rat cardiac myocytes. Mol Pharmacol 59: 867-874, 2001.
16. Hua LL, Zhao ML, Cosenza M, Kim MO, Huang H, Tanowitz HB, Brosnan CF, and Lee SC. Role of mitogen-activated protein kinases in inducible nitric oxide synthase and TNF-α expression in human fetal astrocytes. J Neuroimmunol 126: 180-189, 2002.
17. Ip YT and Davis RJ. Signal transduction by the c-Jun N-terminal kinase (JNK)-from inflammation to development. Curr Opin Cell Biol 10: 205-219, 1998.
18. Jana M, Anderson JA, Saha RN, Liu X, and Pahan K. Regulation of inducible nitric oxide synthase in proinflammatory cytokine-stimulated human primary astrocytes. Free Radic Biol Med 38: 655-664, 2005.
19. Kuan CY, Whitmarsh AJ, Yang DD, Liao G, Schloemer AJ, Dong C, Bao J, Banasiak KJ, Haddad GG, Flavell RA, Davis RJ, and Rakic P. A critical role of neural-specific JNK3 for ischemic apoptosis. Proc Natl Acad Sci USA 100: 15184-15189, 2003.
20. Kumagae Y, Zhang Y, Kim OJ, and Miller CA. Human c-Jun N-terminal kinase expression and activation in the nervous system. Brain Res Mol Brain Res 67: 10-17, 1999.
21. Liu B, Gao HM, Wang JY, Joehn GH, Cooper CL, and Hong JS. Role of nitric oxide in inflammation mediated neurodegeneration. Ann NY Acad Sci 962: 318-331, 2002.
22. Liu J, Minemoto Y, and Lin A. c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis. Mol Cell Biol 24: 10844-10856, 2004.
23. Nakamura Y. Regulating factors for microglial activation. Biol Pharm Bull 25: 945-953, 2002.
24. Nishina H, Wada T, and Katada T. Physiological roles of SAPK/JNK signaling pathway. J Biochem (Tokyo) 136: 123-126, 2004.
25. Pawate S, Shen Q, Fan F, and Bhat NR. Redox regulation of glial inflammatory response to lipopolysaccharide and interferongamma. J Neurosci Res 77: 540-551, 2004.
26. Saha RN and Pahan K. Regulation of inducible nitric oxide synthase gene in glial cells. Antioxid Redox Signal 8: 929-947, 2006.
27. Smith KJ and Lassmann H. The role of nitric oxide in multiple sclerosis. Lancet Neurol 1: 232-241, 2002.
28. Waetzig V, Czeloth K, Hidding U, Mielke K, Kanzow M, Brecht S, Goetz M, Lucius R, Herdegen T, and Hanisch UK. c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia. GLIA 50: 235-246, 2005.
29. Yan M, Dai T, Deak JC, Kyriakis JM, Zon LI, Woodgett JR, and Templeton DJ. Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1. Nature 372: 798-800, 1994.
30. Zhang P, Miller BS, Rosenzweig SA, and Bhat NR. Activation of C-jun N-terminal kinase/stress-activated protein kinase in primary glial cultures. J Neurosci Res 46: 114-21, 1996.
31. Zhang P, Hogan EL, and Bhat NR. Activation of JNK/SAPK in primary glial cultures: II. Differential activation of kinase isoforms corresponds to their differential expression. Neurochem Res 23: 219-225, 1998.